| Molecular genetics of human obesity: A comprehensive review RK Singh, P Kumar, K Mahalingam Comptes rendus biologies 340 (2), 87-108, 2017 | 300 | 2017 |
| Diagnosis of mucopolysaccharidoses: how to avoid false positives and false negatives K Mahalingam, S Janani, S Priya, EM Elango, RM Sundari The Indian Journal of Pediatrics 71, 29-32, 2004 | 54 | 2004 |
| Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells A Khanna, K Mahalingam, D Chakrabarti, G Periyasamy Cellular & molecular biology letters 16, 101-113, 2011 | 39 | 2011 |
| Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma Y Paul, S Thomas, V Patil, N Kumar, B Mondal, AS Hegde, A Arivazhagan, ... Oncotarget 9 (51), 29548, 2018 | 31 | 2018 |
| Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma S Bhargava, V Patil, K Mahalingam, K Somasundaram Oncotarget 8 (10), 16650, 2017 | 28 | 2017 |
| In silico approach to identify non-synonymous SNPs in human obesity related gene, MC3R (melanocortin-3-receptor) RK Singh, K Mahalingam Computational Biology and Chemistry 67, 122-130, 2017 | 18 | 2017 |
| A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma V Patil, K Mahalingam Gene 679, 57-64, 2018 | 17 | 2018 |
| Global RNA editome landscape discovers reduced RNA editing in glioma: Loss of editing of gamma-amino butyric acid receptor alpha subunit 3 (GABRA3) favors glioma migration and … V Patil, J Pal, K Mahalingam, K Somasundaram PeerJ 8, e9755, 2020 | 16 | 2020 |
| Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes V Patil, K Mahalingam Gene 685, 85-95, 2019 | 16 | 2019 |
| In silico approach to identify non-synonymous SNPs with highest predicted deleterious effect on protein function in human obesity related gene, neuronal growth regulator 1 (NEGR1) P Kumar, K Mahalingam 3 Biotech 8, 1-16, 2018 | 13 | 2018 |
| Androgen insensitivity syndrome: ten years of our experience A Subramaniam, R Singh, P Tilak, R Devi, M Kulandaivelu, ... Front Biosci (Elite Ed) 5 (2), 779-784, 2013 | 12 | 2013 |
| Structural and functional analysis of N-acetylgalactosamine-6-sulfate sulfatase using bioinformatics tools: insight into Mucopolysaccharidosis IVA SC Sudhakar, K Mahalingam J Pharm Res 4 (11), 3958-3962, 2011 | 10 | 2011 |
| In silico analysis of fat mass obesity associated (FTO) gene using computational algorithms P Kumar, RK Singh, K Mahalingam Int J Pharma Bio Sci 6, B589-B599, 2015 | 5 | 2015 |
| Mucopolysaccharidosis type I: Homology modeling and docking analysis of the lysosomal enzyme, human α-L-iduronidase SSCK Mahalingam African Journal of Pharmacy and Pharmacology 6 (27), 2027-2038, 1922 | 5* | 1922 |
| In silico analysis of Snps in human obesity related gene, SLC6A14 (solute carrier family 6 (amino acid transporter), member 14) RK Singh, P Kumar, K Mahalingam Int J Pharm Bio Sci, 248-256, 2016 | 4 | 2016 |
| SRY (Sex Determining Regions in Y) Basis of Sex Reversal in XY Females S Amudha, S Rajangam, K Thangaraj, K Mahalingam International Journal of Human Genetics 12 (2), 99-103, 2012 | 2 | 2012 |
| Heterochromatin Variations in Infertile Men LC Sofia, P Chinnaswami, K Mahalingam International Journal of Human Genetics 16 (1-2), 22-28, 2016 | | 2016 |
| A STUDY ON DNA BINDING AFFINITY OF CHEMICALS PRESENT IN COSMETIC PRODUCTS USING BIOINFORMATICS TOOLS KM IMRAN KHAN, MOHD.FARHAN, PRATICHI SINGH INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE 2 (6), 407-421, 2013 | | 2013 |
| Clinical biochemical and molecular studies on Mucopolysaccharidosis I in South Indian K Mahalingam Chennai, 0 | | |
| INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE ROY SATARUPA, A GAIKWAD, K SHALINI, K MAHALINGAM | | |
